Treatment of upper urinary tract urothelial carcinoma

Surgical Oncology

Volumn 20, Issue 1, 2011, Pages 43-55

  Cai, Guiyang ^a   Liu, Xuefeng ^a   Wu, Bin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Endoscopic; Genetic; Immunotherapy; Laparoscopic; Molecular; Radiotherapy; Urothelial carcinoma

Indexed keywords

ALBINTERFERON ALPHA2B; BCG VACCINE; BROPIRIMINE; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; METHOTREXATE; MITOMYCIN C; VINBLASTINE;

CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CYSTOSCOPY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SURGERY; HUMAN; IMMUNOTHERAPY; LAPAROSCOPIC SURGERY; LYMPHADENECTOMY; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEPSIS; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER URINARY TRACT UROTHELIAL CARCINOMA; URETEROSCOPY;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; LYMPHATIC METASTASIS; NEOPLASM STAGING; ROBOTICS; TUMOR MARKERS, BIOLOGICAL; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 78650823270     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2009.10.001     Document Type: Review

References (64)

1. E.M. Genega, and C.R. Porter Urothelial neoplasms of the kidney and ureter: an epidemiologic, pathological and clinical review Am J Clin Pathol 117 Suppl 2002 Jun S36 S48
2. K.C. Latchamsetty, and C.R. Porter Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy Rev Urol 8 2 2006 61 70 Spring
3. F.N. Joudi, C.N. Crane, and M.A. O'Donnell Minimally invasive management of upper tract urothelial carcinoma Curr Urol Rep 7 1 2006 Jan 23 30
4. M.F. Arancibia, C. Bolenz, M.S. Michel, F.X. Keeley Jr., and P. Alken The modern management of upper tract urothelial cancer: surgical treatment BJU Int 99 2007 978 981
5. Jay D. Raman, and Douglas S. Scherr Management of patients with upper urinary tract transitional cell carcinoma Nat Clin Pract Urol 4 8 2007 Aug 432 443
6. M.C. Hall, S. Womack, A.I. Sagalowsky, T. Carmody, M.D. Erickstad, and C.G. Roehrborn Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients Urology 52 4 1998 Oct 594 601
7. C. Langner, G. Hutterer, T. Chromecki, I. Winkelmayer, P. Rehak, and R. Zigeuner pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract Mod Pathol 19 2006 272 279 (Pubitemid 43117612)
8. G. Novara, V. De Marco, F. Gottardo, O. Dalpiaz, V. Bouygues, and A. Galfano Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers Cancer 110 8 2007 Oct 15 1715 1722
9. W. Oosterlinck, E. Solsona, A.P.M. van der Meijden, R. Sylvester, A. Böhle, and E. Rintala EAUGuidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma Eur Urol 46 2004 147 154
10. Richard Zigeuner, and Karl Pummer urothelial carcinoma of the upper urinary tract:surgical approach and prognostic factors Eur Urol 53 2008 720 731
11. Marco Roscigno, Cesare Cozzarini, Roberto Bertini, Vincenzo Scattoni, Massimo Freschi, and Luigi Filippo Da Pozzo Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract Eur Urol 53 2008 794 802
12. H. Komatsu, N. Tanabe, S. Kubodera, H. Maezawa, and A. Ueno The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract J Urol 157 5 1997 1622 1624
13. H. Miyake, I. Hara, K. Gohji, S. Arakawa, and S. Kamidono The significance of lymphadenectomy in transitional cell carcinoma of the upper urinary tract Br J Urol 82 4 1998 Oct 494 498
14. M.A. Brausi, M. Gavioli, G. De Luca, G. Verrini, G. Peracchia, and G. Simonini Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival Eur Urol 52 5 2007 Nov 1414 1418
15. E. Guarnizo, C.P. Pavlovich, M. Seiba, D.L. Carlson, E.D. Vaughan Jr., and R.E. Sosa Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach J Urol 163 1 2000 Jan 52 55
16. F.X. Keeley, D.A. Kulp, M. Bibbo, P.A. McCue, and D.H. Bagley Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma J Urol 157 1 1997 Jan 33 37 (Pubitemid 26414922)
17. F.P. Secin, T.M. Koppie, J.I. Salamanca, S. Bokhari, G.V. Raj, and S. Olgac Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer Int J Urol 14 1 2007 Jan 26 32
18. U. Maier, G. Mertl, K. Pummer, W. Höltl, W. Tomschi, and C. Mrstik Organ-preserving surgery in patients with urothelial tumors of the upper urinary tract Eur Urol 18 3 1990 197 200
19. K.S. Pohar, and J. Sheinfeld When is partial ureterectomy acceptable for transitional-cell carcinoma of the ureter? J Endourol 15 4 2001 May 405 408 [discussion 409]
20. J. Lehmann, H. Suttmann, I. Kovac, M. Hack, J. Kamradt, and S. Siemer Transitional cell carcinoma of the ureter: prognostic factors influencing progression and survival Eur Urol 51 5 2007 May 1281 1288
21. R.V. Clayman, L.R. Kavoussi, R.S. Figenshau, P.S. Chandhoke, and D.M. Albala Laparoscopic nephroureterectomy: initial clinical case report J Laparoendosc Surg 1 6 1991 Dec 343 349
22. K.W. Kercher, B.T. Heniford, B.D. Matthews, T.I. Smith, A.E. Lincourt, and D.H. Hayes Laparoscopic versus open nephrectomy in 210 consecutive patients: outcomes, cost, and changes in practice patterns Surg Endosc 17 12 2003 Dec 1889 1895
23. Jens J. Rassweiler, Michael Schulze, Reinaldo Marrero, Thomas Frede, Juan Palou Redorta, and Pierfrancesco Bassi Laparoscopic nephroureterectomy for upper urinary tract transitional cell Carcinoma: is it better than open surgery? Eur Urol 46 2004 690 697
24. Andre Berger, and Amr Fergany Laparoscopic nephroureterectomy: oncologic outcomes and management of distal ureter; review of the literature Adv Urol 2009 826725
25. Davis P. Viprakasit, Amanda M. Macejko, and Robert B. Nadler Laparoscopic nephroureterectomy and management of the distal ureter: a review of current techniques and outcomes Adv Urol 2009 721371
26. K. Rose, S. Khan, H. Godbole, J. Olsburgh, P. Dasgupta GUY'S and St. Thomas' Robotics Group Robotic assisted retroperitoneoscopic nephroureterectomy - first experience and the hybrid port technique Int J Clin Pract 60 1 2006 Jan 12 14
27. D.K. Nanigian, W. Smith, and L.M. Ellison Robot-assisted laparoscopic nephroureterectomy J Endourol 20 7 2006 Jul 463 465 [discussion 465-6]
28. J. Landman, R.Y. Lev, S. Bhayani, G. Alberts, J. Rehman, and J.G. Pattaras Comparison of hand assisted and standard laparoscopic radical nephroureterectomy for the management of localized transitional cell carcinoma J Urol 167 6 2002 Jun 2387 2391
29. M. Muntener, M.E. Nielsen, F.R. Romero, E.M. Schaeffer, M.E. Allaf, and F.A. Brito Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma Eur Urol 51 6 2007 Jun 1639 1644
30. A. Berger, G.P. Haber, K. Kamoi, M. Aron, M.M. Desai, and J.H. Kaouk Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years J Urol 180 3 2008 Sep 849 854 [discussion 854]
31. M. Rouprêt, V. Hupertan, K.M. Sanderson, J.D. Harmon, X. Cathelineau, and E. Barret Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience Urology 69 4 2007 Apr 656 661
32. M. Waldert, M. Remzi, H.C. Klingler, L. Mueller, and M. Marberger The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy BJU Int 103 1 2009 Jan 66 70
33. Georgios Koukourakis, Georgios Zacharias, Michael Koukourakis, Kiriaki Pistevou-Gobaki, Christos Papaloukas, and Athanasios Kostakopoulos Comprehensive management of upper tract urothelial carcinoma Adv Urol 2009 656521
34. K. Moore, J. Khastgir, and M. Ghei Endoscopic management of upper tract urothelial carcinoma Adv Urol 2009 620604
35. Bader Mj, R. Sroka, and C. Gratzke Laser therapy for upper urinary tract transitional cell carcinoma: indications and management Eur Urol 2008 10.1016/j.eururo.2008.12.012
36. GBlake Johnson, and Michael Grasso Ureteroscopic management of upper urinary tract transitional cell carcinoma Curr Opin Urol 15 2 2005 Mar 89 93
37. Sangtae Park, and Maxwell V. Meng Endoscopic and minimally invasive approaches to upper tract urothelial carcinoma Curr Opin Urol 15 5 2005 Sep 336 341
38. M.C. Goel, V. Mahendra, and J.G. Roberts Percutaneous management of renal pelvic urothelial tumors: long-term followup J Urol 169 3 2003 Mar 925 929
39. Amanda M. Macejko, Joseph F. Pazona, Stacy Loeb, Simon Kimm, and Robert B. Nadler Management of distal ureter in laparoscopic nephroureterectomy - a comprehensive review of techniques Urology 72 5 2008 Nov 974 981
40. R. Ko, B.H. Chew, D.R. Hickling, H. Razvi, P.P. Luke, and J.L. Chin Transitional-cell carcinoma recurrence rate after nephroureterectomy in patients who undergo open excision of bladder cuff v transurethral incision of the ureteral orifice J Endourol 21 7 2007 Jul 730 734
41. I.S. Gill, J.J. Soble, S.D. Miller, and G.T. Sung A novel technique for management of the en bloc bladder cuff and distal ureter during laparoscopic nephroureterectomy J Urol 161 2 1999 Feb 430 434
42. I.S. Gill, G.T. Sung, M.G. Hobart, S.J. Savage, A.M. Meraney, and D.K. Schweizer Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland clinic experience J Urol 164 5 2000 Nov 1513 1522
43. B. Giovansili, M. Peyromaure, D. Saïghi, T. Dayma, M. Zerbib, and B. Debré Stripping technique for endoscopic management of distal ureter during nephroureterectomy: experience of 32 procedures Urology 64 3 2004 Sep 448 452 [discussion 452]
44. A.L. Shalhav, M.D. Dunn, A.J. Portis, A.M. Elbahnasy, E.M. McDougall, and R.V. Clayman Laparoscopic nephroureterectomy for upper tract transitional cell cancer: the Washington University experience J Urol 163 4 2000 Apr 1100 1104
45. R. Hattori, Y. Yoshino, M. Gotoh, M. Katoh, O. Kamihira, and Y. Ono Laparoscopic nephroureterectomy for transitional cell carcinoma of renal pelvis and ureter: Nagoya experience Urology 67 4 2006 Apr 701 705
46. M.F. Sarosdy, L.L. Pisters, P.R. Carroll, M.C. Benson, T.D. Moon, and D.L. Lamm Bropirimine immunotherapy of upper urinary tract carcinoma in situ Urology 48 1 1996 Jul 28 32
47. G.N. Thalmann, R. Markwalder, B. Walter, and U.E. Studer Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery J Urol 168 4 Pt 1 2002 Oct 1381 1385
48. M.H. Katz, M.W. Lee, and M. Gupta Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B J Endourol 21 4 2007 Apr 374 377
49. H. Koga, and S. Naito Recent progress in the treatment for urothelial cancer Gan Kagaku Ryoho 33 2 2006 Feb 164 170
50. Peter H. O'Donnell, and Walter M. Stadler The role of chemotherapy in upper tract urothelial carcinoma Adv Urol 2009 419028
51. M. Igawa, S. Urakami, H. Shiina, H. Kishi, Y. Himeno, and T. Ishibe Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract Urol Int 55 2 1995 74 77
52. N. Soga, K. Arima, and Y. Sugimura Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma Int J Urol 15 9 2008 Sep 800 803
53. J.T. Roberts, H. von der Maase, L. Sengeløv, P.F. Conte, L. Dogliotti, and T. Oliver Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/ cisplatin in patients with locally advanced and metastatic bladder cancer Ann Oncol 17 Suppl. 5 2006 May v118 v122
54. C.N. Sternberg, S.M. Donat, J. Bellmunt, R.E. Millikan, W. Stadler, and P. De Mulder Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer Urology 69 Suppl. 1 2007 Jan 62 79
55. R.H. Houston, and B.C. Leibovich Management of upper tract tumors N.J. Vogelzang, P.T. Scardino, W.U. Shipley, D.S. Coffey, 3rd ed. Comprehensive Textbook of Genitourinary Oncology vol. 1 2005 Lippincott Williams & Wilkins Philadelphia, PA, USA 435 442
56. S.F. Shariat, G.S. Palapattu, P.I. Karakiewicz, C.G. Rogers, A. Vazina, and P.J. Bastian Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy Eur Urol 51 1 2007 Jan 137 149
57. R.F. Sánchez-Ortiz, W.C. Huang, R. Mick, K.N. Van Arsdalen, A.J. Wein, and S.B. Malkowicz An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma J Urol 169 1 2003 Jan 110 115
58. S.S. Chang, J.M. Hassan, M.S. Cookson, N. Wells, and J.A. Smith Jr. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage J Urol 170 4 Pt 1 2003 Oct 1085 1087
59. M. May, T. Nitzke, C. Helke, H. Vogler, and B. Hoschke Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder Scand J Urol Nephrol 38 3 2004 231 235
60. P.E. Clark Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer Expert Rev Anticancer Ther 9 6 2009 Jun 821 830
61. C. Maulard-Durdux, A. Méjean, B. Dufour, C. Hennequin, Y. Chrétien, and B. Vignes Value of postoperative radiotherapy in malignant tumors of the upper urinary tract. Apropos of a series of 26 patients Bull Cancer 83 11 1996 Nov 940 944
62. B. Chauvet, C. Félix-Faure, J.L. Davin, C. Choquenet, M. Alfonsi, and F. Reboul Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival Cancer Radiother 2 Suppl. 1 1998 Apr 85s 91s
63. M.H. Hussain, T.R. Glass, J. Forman, W. Sakr, D.C. Smith, and M. Al-Sarraf Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study J Urol 165 1 2001 Jan 56 60
64. C.S. Higano, C.M. Tangen, W.A. Sakr, J. Faulkner, S.E. Rivkin, and F.J. Meyers Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733 Cancer 112 10 2008 May 15 2181 2187